Pharmacy Toolkit
NOTE: You must login to your Alliance account to access the articles and resources below. Some content may only be accessible to Alliance members.
Featured Toolkits
Vendor Accountability Initiative | 2022 Poster Project | COVID-19 | DE&I | FWA Case Sharing | Healthcare Policy | Interoperability | Leadership Org Charts | Maternal Health | Medicare Advantage | Member Experience | No Surprises Act | Pharmacy | Policy and Procedures | Risk Adjustment/Coding | SDoH | Star Ratings
Presentation: Opioid Management Health Alliance Plan
Health Alliance Plan presents on strategies and initiatives to address more effective opioid management at our Pharmacy networking meeting in Dallas, May 2018.
Presentation: Strategies for MA STAR Ratings Success
Scott & White Health Plan and Presbyterian Health Plan provide effective strategies to help optimize plan success with Medicare Advantage STAR ratings at the Pharmacy networking meeting in Dallas, May 2018.
2018 and Beyond: Pharmacy Outlook and Turning Points
IQVIA presents the outlook for pharmacy 2018 and beyond.
Biotech and Spec Pharma: A deeper look into copay accumulators - mechanisms, near term impact, pharma counter strategies
This Bernstein & Co. article explores the implications of copay accumlulators for biotech and specialty pharmaceuticals.
Global Pharmaceuticals: 1Q18 EPS preview - model changes & updated perspectives
Bernstein & Company announce highlights and upcoming Q1 EPS results for their ten covered US/EU pharmaceutical companies.
US Healthcare Services: How to evaluate middlemen margins, and why we believe PBM margins are very high
This Bernstein article highlights reasons why PBM margins are so high.
Opioid-Related Reforms Moving Towards Senate Mark-Up
Cowen Washington Research Group provides an update on opioid-related reforms.
2017 Trends in Drug Benefit Design
PBMI presents 2017 Trends in Drug Benefit Design Report.
2018 Trends in Specialty Drug Benefits
Pharmacy Benefits Management Institute provides insights into key trends in specialty pharmacy benefits.
Understanding the Drivers of Drug Expenditure in the U.S.
This brief from QuintilesIMS Institute provides analysis around a key aspect of medicine spending growth trends: manufacturer net revenues.